Industry Members

ISCT Industry Membership Benefits

Access a global network of  Key Opinion Leaders in cell and gene therapy translation

ISCT provides a unique collaborative environment, structured into three pillars of clinical translation:

  • Academia
  • Regulatory
  • Commercialization

Increase visibility for your company amongst leading organizations 

The ISCT Industry Committee consists of a mix of leading therapeutic developers, CDMOs, tools, service, and product providers, plus academic thought leaders with the mandate of identifying and challenging the roadblocks to cell and gene therapy commercialization.

Contribute to consensus-building educational resources

The Commercialization Committees develop subject-matter focused publications, webinars and reports to set industry standards on critical topics relevant to the development and delivery of cell and gene therapies. 

    *Participation within the Commercialization Committee(s) is contingent on an Industry Community Membership with ISCT as outlined below.

    Extend ISCT member benefits to your R&D and process development teams 

    Industry members have access to a complimentary laboratory membership which includes ISCT membership accounts for technical staff members working "at the bench", contributing to the clinical translation of cell and gene therapies.

    2024 ISCT Industry Community Members


    Akron Biotech logo


    Azenta Logo

    CCRM logo

    Cell Therapies logo

    Cellares logo

    Cryoport logo

    FUJIFILM logo

    gateway analytical logo

    Miltenyi Biotec logo

    OriGen Biomedical | Cryopreservation & Cell Culture ...

    sartorius logo

    ThermoFisher Scientific logo

    ViroCell Biologics

    West logo


    Aseptic Techonologies logo

    GenScript and Avectas Team Up to Improve the Non-Viral Cell Therapy  Manufacturing Process

    Cook Myosite Inc.

    NextCell Pharma AB (@NextCellPharma) / Twitter

    pluristyx logo